BPOC, a pure-play healthcare private equity investor, has partnered with Mark Scullion, an experienced pharmaceutical executive, to build a clinical research site platform for the pharmaceutical industry.
Scullion brings 15 years of experience in the clinical research industry with knowledge of the site selection process and the needs of pharmaceuticals to the partnership. Going forward, BPOC and Scullion will work to build a site network through both organic and acquisitions growth that will leverage a centralized platform to handle pain points for pharmaceutical sponsors.
“Creating a platform of scale with centralized management and sophisticated systems will be a significant asset to patients, sites, and pharma sponsors,” said Scullion. “BPOC is an ideal partner given their strong track record in the healthcare space with more than 25 years of experience, and I am confident that with the team we will build a successful platform.”